SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

11 Nov 2022 Evaluate
Revenue reduced marginally to stand at Rs. 536.23 millions during the quarter ended September 2022. The figure stood at Rs. 562.25 millions during the year-ago period.The Total revenue for the quarter ended September 2022 of  Rs. 178.87  millions  grew by 373.70% from Rs. 37.76 millions.Operating profit for the quarter ended September 2022 rose to 206.43 millions as compared to 65.72 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 536.23 562.25 -4.63 1248.03 854.45 46.06 2045.20 2228.33 -8.22
Other Income 147.38 19.72 647.36 149.11 43.23 244.92 80.27 104.14 -22.92
PBIDT 206.43 65.72 214.11 272.99 94.45 189.03 234.40 406.14 -42.29
Interest 6.13 5.26 16.54 11.08 11.81 -6.18 29.53 38.07 -22.43
PBDT 200.30 60.46 231.29 261.91 82.64 216.93 204.87 368.07 -44.34
Depreciation 11.23 10.88 3.22 22.04 21.65 1.80 43.23 41.03 5.36
PBT 189.07 49.58 281.34 239.87 60.99 293.29 161.64 327.04 -50.57
TAX 10.20 11.82 -13.71 22.96 14.52 58.13 44.20 92.33 -52.13
Deferred Tax -1.74 3.05 -157.05 -2.76 3.76 -173.40 6.73 34.76 -80.64
PAT 178.87 37.76 373.70 216.91 46.47 366.77 117.44 234.71 -49.96
Equity 482.11 432.52 11.47 482.11 432.52 11.47 482.12 432.52 11.47
PBIDTM(%) 38.50 11.69 229.35 21.87 11.05 97.88 11.46 18.23 -37.12

Kopran Share Price

161.05 0.30 (0.19%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×